Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
1.100
-0.075 (-6.38%)
Feb 10, 2026, 5:22 PM CET
-68.57% (1Y)
| Market Cap | 33.44M -60.8% |
| Revenue (ttm) | 36.76M +14.2% |
| Net Income | -25.78M |
| EPS | -0.94 |
| Shares Out | 30.40M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 59,509 |
| Average Volume | 85,342 |
| Open | 1.175 |
| Previous Close | 1.175 |
| Day's Range | 1.100 - 1.245 |
| 52-Week Range | 0.972 - 3.500 |
| Beta | 1.18 |
| RSI | 51.48 |
| Earnings Date | Jan 21, 2026 |